Asensus Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 04:05 pm EDT
Share
Asensus Surgical, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.494 million compared to USD 0.316 million a year ago. Revenue was USD 1.08 million compared to USD 0.994 million a year ago. Net loss was USD 20.66 million compared to USD 19.62 million a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.08 a year ago.
For the six months, sales was USD 0.982 million compared to USD 0.727 million a year ago. Revenue was USD 2.06 million compared to USD 2.06 million a year ago. Net loss was USD 42.88 million compared to USD 38.75 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.16 a year ago.
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
ASENSUS SURGICAL, INC. 
